Related by context. All words. (Click for frequent words.) 73 psychosocial functioning 71 HRQOL 70 carotid IMT 70 adrenal function 70 hippocampal volume 68 HRQL 68 serum lipid levels 68 serum BDNF 68 premorbid 67 MMSE score 67 neurocognitive functioning 67 antioxidant supplementation 67 growth hormone secretion 67 comorbid depression 67 WOMAC pain 67 liver histology 67 APOE genotype 67 cognitive function 67 poststroke 67 spirometric 67 neurodevelopmental outcome 67 albumin excretion 67 cognitive functioning 66 psychosocial variables 66 MMSE scores 66 metabolic parameters 66 ADAS Cog 66 androgen deprivation 66 intact parathyroid hormone 66 psychiatric comorbidities 66 T1DM 66 posttreatment 66 systolic function 66 autonomic dysfunction 66 serum PTH 66 psychiatric comorbidity 65 cardiac autonomic 65 hippocampal volumes 65 left ventricular systolic 65 inflammatory biomarkers 65 GH deficiency 65 comorbid anxiety 65 pharmacodynamic parameters 65 serum lipid 65 depressive symptomatology 65 extrapyramidal symptoms 65 β blockers 65 lipid profiles 65 androgen depletion 65 neuritic 65 cortisol secretion 65 glomerular filtration 65 Leydig cell 65 thyrotropin levels 65 lipid parameters 65 myocardial function 65 glycosylated hemoglobin HbA1c 65 posttransplant 65 pharmacological therapies 65 daytime alertness 65 Depressive symptoms 64 neurocognitive 64 neurocognitive deficits 64 serum calcium levels 64 metabolite concentrations 64 prostate cancer CaP 64 histological subtype 64 cerebral oxygenation 64 colorectal adenoma 64 prognostic variables 64 serum phosphate 64 glucose homeostasis 64 meta regression 64 serum estradiol 64 neurobehavioural 64 hsCRP levels 64 cognitive domains 64 univariate analyzes 64 QoL 64 left ventricular diastolic 64 bone microarchitecture 64 leukocyte counts 64 anticholinergic agents 64 affective psychoses 64 abstinent alcoholics 64 multivariable adjusted 64 radiographic findings 64 aminotransferases 64 HRQoL 64 artery stenosis 64 postoperative AF 64 prognostic indicators 64 diabetes mellitus DM 64 affective psychosis 64 postoperative mortality 64 EGFR mutation status 64 euthymic patients 64 plasma lipids 64 diastolic function 64 neurodevelopmental outcomes 64 echocardiographic parameters 64 aMCI precursor 64 tissue oxygenation 64 sociodemographic factors 64 cranial irradiation 64 shorter telomere length 64 sociodemographic characteristics 63 mixed hyperlipidemia 63 synaptic function 63 tumor histology 63 cardiac repolarization 63 Subgroup analysis 63 Cognitive behavioral 63 decompensated cirrhosis 63 fasting insulin 63 MetS 63 coronary calcification 63 multivariate analyzes 63 HOMA IR 63 Logistic regression 63 beta blocker therapy 63 nondepressed 63 estimated glomerular filtration 63 analgesic medications 63 baseline LDH 63 neurosensory 63 ALSFRS R 63 clinicopathological 63 neurologic outcomes 63 multivariable analysis 63 symptomatic VTE 63 postintervention 63 intima media thickness 63 haematologic 63 ERalpha 63 Cystatin C 63 convergent validity 63 exploratory endpoints 63 Suicidal ideation 63 Logistic regression analysis 63 NYHA functional class 63 neuro cognitive 63 BMI z 63 euthymic 63 affective disorders 63 urate levels 63 protein excretion 63 EQ 5D 63 symptom severity 63 serum calcium 63 plasma leptin 63 vascular reactivity 63 QTc intervals 63 cerebral perfusion 63 plasma creatinine 63 normotensive 63 predictive validity 63 proliferative diabetic retinopathy 63 HbA 1c levels 63 Genetic variants 63 hippocampal function 63 HAQ DI 63 ABCB1 63 Erectile function 63 platelet activation 63 venlafaxine XR 63 inotropic 63 antidiabetic medication 63 lesional 63 antiarrhythmic medications 63 hematopoietic cancers 63 multivariate logistic regression 63 comorbid disorders 63 APOE ε4 63 electrophysiologic 63 Univariate 62 airflow obstruction 62 pituitary hormone 62 lactate dehydrogenase 62 PsA 62 kidney allograft 62 International Prostate Symptom 62 logistic regression analyzes 62 prostate carcinogenesis 62 rCBF 62 serum concentrations 62 albumin excretion rate 62 lung function 62 hematological parameters 62 glycosylated hemoglobin levels 62 HPA axis 62 cortical atrophy 62 overactive bladder symptoms 62 Visual acuity 62 serum testosterone levels 62 primary aldosteronism 62 cardiorespiratory fitness 62 paricalcitol 62 F FDG PET 62 multivariate Cox 62 telomere lengths 62 neuropathological 62 potassium sparing diuretics 62 mammographic density 62 intravascular hemolysis 62 elevated IOP 62 neurocognitive impairment 62 PSADT 62 MDRD 62 white matter hyperintensities 62 comorbidity 62 glucose tolerance 62 CYP#D# genotype 62 antidepressant efficacy 62 fractional anisotropy 62 overt nephropathy 62 SIADH 62 serum parathyroid hormone 62 thyrotropin 62 nonischemic 62 alexithymia 62 chemosensitivity 62 anti Mullerian hormone 62 preoperative chemotherapy 62 intravenous cyclophosphamide 62 hypogonadal men 62 neutrophil counts 62 hepatic enzymes 62 T2DM 62 hypogonadal 62 SGPT 62 Subgroup analyzes 62 thyroid hormone levels 62 baroreflex 62 inotropic agents 62 alanine aminotransferase ALT 62 akinesia 62 subclinical atherosclerosis 62 nonpharmacologic 62 Postoperative 62 ventricular remodeling 62 intracranial stenosis 62 autoregulation 62 parkinsonian 62 p# activation 62 neuroleptic 62 CP CPPS 62 pre operatively 62 Endothelial function 62 bronchopulmonary dysplasia BPD 62 conditional logistic regression 62 atypical neuroleptics 62 nerve conduction velocity 62 renal function 62 periprocedural MI 62 loop diuretics 62 mRNA expression 62 androgen deficiency 62 multivariate adjustment 62 pelvic lymphadenectomy 62 STEP BD 62 QT intervals 62 TT genotype 62 Multivariate logistic regression 62 serum GGT 62 hematologic parameters 62 serum vitamin D 62 genotypic resistance 62 NIH CPSI 62 aspirin NSAIDs 62 euthyroid 62 Sjögren syndrome 62 HNSCC 62 pyridostigmine 62 Univariate analysis 62 serum TSH 62 subscale scores 62 preintervention 62 adiponectin levels 62 CPAP adherence 62 multiple logistic regression 62 pulmonary exacerbations 62 diabetic polyneuropathy 62 attain statistical significance 62 hepatic insulin sensitivity 62 BEXXAR Therapeutic Regimen 62 Multiple logistic regression 62 renal fibrosis 62 amnestic mild cognitive impairment 62 Index CDAI 62 extracellular dopamine 62 neovascular 61 N telopeptide 61 EphB2 levels 61 HER2 expression 61 oral antidiabetes 61 arterial thickening 61 airway reactivity 61 parkinsonism 61 prognostic significance 61 plasma triglycerides 61 thiopurine 61 chronicity 61 serum cortisol 61 Heavy menstrual bleeding 61 hip BMD 61 carotid stenosis 61 lactate dehydrogenase LDH 61 neuronal function 61 Y BOCS 61 impaired glucose metabolism 61 intraobserver 61 Secondary endpoints 61 hepatorenal syndrome 61 salivary cortisol 61 GABRA2 61 torsade de pointes 61 mucosal healing 61 femoral neck BMD 61 neuropsychological deficits 61 lipoprotein levels 61 comorbid psychiatric 61 locomotor activity 61 HIV HCV coinfected 61 myocardial viability 61 adenoma recurrence 61 preoperative PSA 61 abdominal adiposity 61 histopathological 61 radiosensitivity 61 hMG 61 electroencephalographic 61 motor neuron degeneration 61 nonvertebral fracture 61 microsatellite instability 61 PANSS scores 61 glycated hemoglobin levels 61 CHD mortality 61 bone metabolism 61 plasma cortisol 61 brachial artery flow 61 AGILECT R 61 interobserver 61 GnRH agonists 61 postoperative pulmonary 61 hydroxyvitamin D levels 61 perioperative complications 61 impaired cognition 61 hepatic fibrosis 61 pharmacological approaches 61 ADCS CGIC 61 Tasigna prolongs 61 plasma pharmacokinetics 61 plasma homocysteine levels 61 CVD mortality 61 lipid lowering agents 61 CTEPH 61 Comorbidity 61 exhaled nitric oxide 61 nonfasting triglyceride levels 61 hepatocellular 61 nonoperative treatment 61 carotid atherosclerosis 61 tic severity 61 monoclonal gammopathy 61 circulating endothelial cells 61 SGRQ 61 Primary endpoints 61 #ß 61 colorectal adenomas 61 coinfected patients 61 postprocedure 61 clomipramine 61 anterior temporal 61 CYP#D# inhibitor 61 erection hardness 61 dyslipidaemia 61 posterior cingulate 61 differential gene expression 61 Crohn Disease Activity 61 hyperphenylalaninemia HPA due 61 Prostatitis 61 univariate 61 myocardial reperfusion 61 adjuvant therapies 61 postoperative complication 61 prednisone prednisolone 61 serum homocysteine 61 glucocorticoid hormones 61 clinically meaningful improvements 61 QTc interval 61 androgenic 61 concomitant medications 61 Multivariate analyzes 61 neuropsychological functioning 61 androgenic hormones 61 familial clustering 61 fluoxetine Prozac 61 hypercalciuria 61 aromatase inhibitors AIs 61 cognitive affective 61 ovarian hormones 61 sudden sensorineural hearing 61 central corneal thickness 61 POAG 61 foveal thickness 61 left ventricular LV 61 prefrontal cortical 61 Symptom severity 61 intraventricular 61 ejection fractions 61 pCR 61 nasal obstruction 61 DNA methylation patterns 61 hyperprolactinemia 61 aromatase inhibitor therapy 61 TPMT 61 serum testosterone 61 angiographically 61 urodynamic 61 biochemical recurrence 61 KRAS status 61 lumbar disk herniation 61 metabolic disturbances 61 airway responsiveness 61 poststroke depression 61 pathophysiological mechanisms 60 apolipoprotein E4 60 SCr 60 testicular function 60 MADRS score 60 clinicopathological features 60 pamidronate 60 AST ALT 60 vasopressor 60 coronary endothelial 60 daytime somnolence 60 pulsatility 60 hippocampal atrophy 60 HSCT 60 logistic regression analysis 60 perioperative morbidity 60 oncological outcomes 60 FDG uptake 60 corticosteroid induced 60 interrater reliability 60 intestinal permeability 60 somatic symptoms 60 surrogate markers 60 brain lesions 60 triiodothyronine 60 prospective multicentre 60 striatal dopamine 60 vasomotor 60 premenopause 60 plasma homocysteine 60 chlamydial infection 60 intravenous diuretics 60 depressive symptom 60 fructosamine 60 adenotonsillectomy 60 lipid levels 60 LUTS 60 urinary albumin 60 Thal Dex 60 serum markers 60 comorbidities 60 hyperparathyroidism 60 Thyroid hormone 60 metaplasia 60 corticosteroid dose 60 pharmacological interventions 60 elevated creatinine 60 pharmacologic treatments 60 diabetic kidney 60 biochemical abnormalities 60 mycophenolate mofetil MMF 60 glaucomatous 60 primidone 60 P = .# 60 Tranexamic acid 60 Thiazolidinediones 60 cortical activation 60 tumor subtype 60 carotid plaques 60 serum sodium 60 arthrography 60 serum cotinine levels 60 receptor subtypes 60 hypothalamic pituitary 60 aspartate aminotransferase AST 60 serum lipids 60 troponin T 60 pharmacologic approaches 60 neuronal plasticity 60 Lumbar spine 60 noncardiac 60 platelet reactivity 60 serum biomarkers 60 plasma renin activity 60 mRS 60 serum bicarbonate 60 transcranial Doppler ultrasound 60 relapsed MM 60 morphometric vertebral fractures 60 serum creatinine levels 60 neuroleptics 60 thyroid stimulating hormone 60 CSF biomarkers 60 repolarization 60 ER CHOP 60 sensory gating 60 comorbid conditions 60 IL 1ß 60 penile erection 60 OSAHS 60 neurological abnormalities 60 VaD 60 virologic response 60 chronic prostatitis chronic 60 APOE e4 60 scintigraphic 60 folate metabolism 60 TNFalpha 60 conventional DMARDs 60 circadian genes 60 neuromotor 60 plasma folate 60 SUVmax 60 CIMZIA TM certolizumab pegol 60 hypertension diabetes mellitus 60 cognition 60 bacterial prostatitis 60 Insulin sensitivity 60 VEGF expression 60 IPAH 60 desvenlafaxine succinate 60 systemic corticosteroid 60 baroreceptor 60 lumbar spine BMD 60 Chronic pancreatitis 60 Angiotensin converting enzyme 60 urine cytology 60 corneal thickness 60 HIV lipodystrophy 60 pretransplant 60 Cognitive impairment 60 serum glucose 60 postinjury 60 tibolone 60 lumbar spine bone 60 transgene expression 60 mIU L 60 stratifying patients 60 neuropsychiatric symptoms 60 endothelial activation 60 thiazide 60 dopaminergic therapy 60 NNT = 60 urinary excretion 60 hemodynamics 60 coagulation parameters 60 neurologic complications 60 preoperatively 60 sperm morphology 60 plasma lipid 60 cerebral glucose metabolism 60 coronary microvascular 60 serum sodium levels 60 CDAI 60 depressive symptoms 60 p# biomarker 60 postmenopausal estrogen 60 hepatocellular carcinomas 60 dietary calcium intake 60 interobserver reliability 60 prolactin elevation 60 ANCOVA 60 antiresorptive 60 Mild Cognitive Impairment 60 nonpsychotic 60 dysfunctional voiding 60 urinary calcium 60 tamoxifen raloxifene 60 logistic regression models 60 oxcarbazepine 60 nodal metastasis 60 serum PSA 60 testosterone supplementation 60 platelet function 60 triglyceride concentrations 60 ADAS cog 60 neurocognition 60 dietary carbohydrate 60 pentoxifylline 60 recurrent glioblastoma multiforme 60 hypothalamic pituitary adrenal axis 60 sargramostim 60 #.#ng/ml 60 amenorrhoea 60 renal allograft 60 oncologic outcomes 60 WOMAC scores 60 levodopa therapy 60 androgen suppression 60 CLA supplementation 60 Cardiorespiratory fitness 60 LHRH agonists 60 PCWP 60 endometrial thickness 60 androgen ablation 60 hyperalgesia 60 multivariable analyzes 60 DLQI 60 HbA1C levels 60 prognostic factors 60 timepoints 60 impair fertility 60 preserved ejection fraction 60 hypoperfusion 60 MGUS 60 Health Assessment Questionnaire 60 chronic thromboembolic pulmonary 60 Cardiotoxicity 60 Radical prostatectomy 60 creatinine levels 60 postoperative atrial fibrillation 60 tertile 60 umol L 60 amisulpride 60 Secondary endpoints included 60 esophageal motility 60 cortical thinning 60 secondary hyperparathyroidism 60 juvenile idiopathic arthritis JIA 60 nonalcoholic steatohepatitis NASH 60 proton MR spectroscopy 60 serum ALT 60 LNG IUS 60 p = .# [002] 60 inotropes 60 vasodilatation 60 antiangiogenic agents 60 mycophenolate mofetil 60 antiandrogens 60 erectile function 60 systolic hypertension 60 ionotropic 60 coadministration 60 laterality 60 urinary cortisol 60 inhibitory neurotransmitters 60 meta analytic 60 subclinical hypothyroidism 60 mild cognitive 60 perfusion abnormalities 60 neurodevelopmental impairment 60 alteplase 60 histone acetylation 60 urinary N telopeptide 60 prostate carcinoma 60 endometrial hyperplasia 60 NIHSS 60 triacylglycerol concentrations 60 endometrial carcinoma 60 neuropathologic 60 vascular dysfunction 60 contrast echocardiography 60 nonobese 60 plasma adiponectin 60 intratympanic 60 glial tumors 60 LV ejection fraction 60 serum clusterin levels 60 neuropsychological 59 MTHFD1L gene 59 femoral neck fracture 59 periprocedural 59 Wernicke Korsakoff syndrome 59 kidney function 59 Androgen 59 transferrin saturation 59 agonist induced 59 calcium homeostasis 59 perimenopausal women 59 seminomas 59 thromboembolic disease 59 macrovascular disease 59 PASI scores 59 Endothelial dysfunction 59 histologic subtype 59 idiopathic intracranial hypertension 59 mucociliary clearance 59 esophageal carcinoma 59 afterload 59 HMG CoA reductase inhibitors 59 calcium antagonists 59 dehydroepiandrosterone sulfate 59 bronchial hyperresponsiveness 59 intermittent hypoxia 59 DHEA supplementation 59 interpersonal psychotherapy 59 polyp detection 59 telomere length 59 NPH insulin 59 nondiabetic patients 59 aspirin clopidogrel 59 phenelzine 59 serum IGF 59 Adjuvant therapy 59 amyloid plaque formation 59 PLX STROKE targeting 59 intestinal motility 59 prolactin levels 59 ERK signaling 59 familial aggregation 59 hemodialysis patients 59 Poisson regression 59 postoperative radiotherapy 59 osteoporotic vertebral compression fractures 59 cytopenias 59 corrected QT interval 59 mucosal inflammation 59 serum folate 59 K ras mutations 59 testicular germ cell 59 urodynamic parameters 59 Natalizumab 59 ovarian function 59 allopregnanolone 59 endothelial function 59 estimated GFR 59 baroreflex sensitivity 59 glycaemia 59 glucocorticoid 59 normal karyotype 59 glycemia 59 Histologic 59 soluble CD# ligand 59 Clusterin 59 bivariate analyzes 59 HRCT 59 Venous thromboembolism 59 thyroglobulin 59 urolithiasis 59 remyelination 59 intracranial hypertension 59 NATRECOR ® 59 thrombotic complications 59 insulin sensitizing drug 59 hepatic enzyme 59 NIHSS score 59 plasma lipoprotein 59 serum uric acid 59 Multivariate analysis 59 Secondary efficacy endpoints 59 HER2 overexpression 59 SSc 59 graft dysfunction 59 OAB symptoms 59 poorer prognosis 59 β amyloid 59 syndromal 59 blood Phe levels 59 serum selenium 59 multivariate regression analysis 59 pharmacodynamic PD 59 cytologic 59 virological response 59 Meta analyzes 59 bladder carcinoma 59 apolipoprotein B 59 subscales 59 AChE inhibitors 59 perioperatively 59 psychophysiological 59 dopamine antagonists 59 neuropsychological assessment 59 parietal cortices 59 neurocognitive outcomes 59 methacholine challenge 59 Psoriasis Area 59 etiologic 59 ICD shocks 59 hypercholesterolaemia 59 ursodeoxycholic acid 59 #q# deletion 59 venous thromboembolic disease 59 undergoing radical prostatectomy 59 neuropsychological impairments 59 hirsutism 59 postoperative delirium 59 coronary artery atherosclerosis 59 salivary flow 59 MDRD equation 59 ELBW infants 59 gene polymorphisms 59 gastrointestinal motility 59 adenomatous 59 progesterone receptor PR 59 μg liter 59 troponins 59 retrospective cohort 59 pleiotropic effects 59 elevated serum creatinine 59 LVNC 59 UGT#A# * 59 somatoform disorders 59 UPDRS 59 VADT 59 androgen hormone 59 TOP2A gene 59 physiologic responses 59 agomelatine 59 meta analytic review 59 retinal thickness 59 symptomatology 59 EDSS scores 59 nondemented 59 oxidative stress markers 59 flutamide 59 myocardial ischemia 59 clinicopathologic 59 Heritability 59 gastric carcinoma 59 Alzheimer Disease Assessment 59 pancreatic adenocarcinoma 59 erythropoietic 59 prospectively stratified 59 logistic regression 59 S#A# [002] 59 squamous cell lung cancer 59 RQ PCR 59 neurologic progression 59 neurobehavioral functioning 59 bioavailable testosterone 59 oral anticoagulation 59 obstructive CAD 59 vasodilators 59 ACh 59 bivariate 59 Sociodemographic 59 cis retinoic acid 59 intraventricular hemorrhage 59 radiochemotherapy 59 moderate renal impairment 59 prostate cancer PCa 59 tertiles 59 cardio respiratory fitness 59 selenium supplementation 59 Neuropsychological 59 gene polymorphism 59 Genetic predisposition 59 allostatic load 59 hypopituitarism 59 tamoxifen Nolvadex ® 59 cytoreductive nephrectomy 59 PSA nadir 59 lipid altering 59 systolic dysfunction 59 primary hyperparathyroidism 59 nonfatal MI 59 gait disturbance 59 cardiotoxic 59 preoperative diagnosis 59 induce remission 59 antiarrhythmic drug 59 Ocular Surface Disease 59 metabolic abnormalities 59 clinically insignificant 59 CC genotype 59 enlarged spleens 59 rheumatoid factor 59 Observational studies 59 Pioglitazone 59 thrombocytopenic 59 cytogenetic abnormalities 59 graft patency 59 clinically localized prostate 59 Unified Parkinson Disease 59 Hyperlipidemia 59 Cotinine 59 antiphospholipid antibodies 59 sociodemographic variables 59 mineral density 59 elevated homocysteine 59 Epworth Sleepiness Scale 59 tricyclic antidepressants TCAs 59 dysglycemia 59 somatostatin analogs 59 cerebral microbleeds 59 node metastases 59 neurobehavioral 59 pathophysiologic 59 nicardipine 59 aortic stiffness 59 recurrent acute pancreatitis 59 haematological 59 citalopram Celexa 59 percutaneous vertebroplasty 59 antidiabetic medications 59 parenchymal 59 SNP rs# [002] 59 LDL HDL 59 amenorrhea 59 covariate 59 biochemical relapse 59 breast carcinoma 59 acetabular dysplasia 59 LVEF 59 asymptomatic carotid stenosis 59 tHcy 59 FGFR2 gene 59 hepatic function 59 HbA 1c 59 vasomotor symptoms 59 atherothrombotic 59 Preoperatively 59 vasoactive 59 symptom exacerbation 59 p# Shc 59 ventricular tachyarrhythmia 59 suicide attempters 59 Adjuvant chemotherapy 59 fasting plasma 59 Negative Symptoms 59 behavioral disinhibition 59 venlafaxine Effexor 59 parasympathetic tone 59 fulvestrant 59 platelet inhibition 59 inflammatory markers 59 radical prostatectomy RP 59 methylation patterns 59 serum triglycerides 59 p = #.# [003] 59 T2 lesion volume 59 IGFBP 3 59 highest tertile 59 TNF blocker therapy 59 flavopiridol 59 Akt activation 59 diagnosing ADHD 59 cerebral infarction 59 thiazide diuretic 59 axonal damage 59 orbitofrontal 59 unmeasured confounding 59 BPH symptom 59 INVEGA ® 59 neuroleptic drugs 59 #F FDG PET 59 ventricular enlargement 59 pulmonary function 59 pulmonary artery banding 59 RAS blockers 59 colorectal carcinogenesis 59 immunosuppressive regimen 59 morphologic 59 pulmonary dysfunction 59 CEACAM1 59 TEAEs 59 specific antigen PSA 59 Doxil ® 59 microalbuminuria 59 coronary stenosis 59 confidence intervals CIs 59 imatinib therapy 59 thromboembolic 59 recurrent miscarriage 59 QTcF 59 underlying pathophysiology 59 creatine kinase 59 testicular tumors 59 endocrinologic 59 carbohydrate metabolism 59 deep venous thromboses 59 genotype phenotype 59 pressor response 59 pharmacodynamic endpoints 59 IBDQ 59 lymphocyte count 59 Secondary endpoints include 58 postoperative morbidity 58 neovascularisation 58 hemodilution 58 CORE OM 58 hemodynamic parameters 58 chromium picolinate supplementation 58 gait disturbances 58 carotid plaque 58 fasting glucose levels 58 choroidal neovascularization 58 urothelial cancer 58 serum folate concentrations 58 c reactive protein 58 inhaled budesonide 58 vessel dilation 58 psychiatric morbidity